2007
DOI: 10.1016/j.jchromb.2006.09.018
|View full text |Cite
|
Sign up to set email alerts
|

Development and validation of a capillary electrophoresis method for the characterization of herpes simplex virus type 1 (HSV-1) thymidine kinase substrates and inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2008
2008
2015
2015

Publication Types

Select...
9

Relationship

4
5

Authors

Journals

citations
Cited by 23 publications
(12 citation statements)
references
References 49 publications
0
12
0
Order By: Relevance
“…Thus, the buffer combination phosphate-HEPES was chosen for the subsequent assay development. The ionic strength of the running buffer is also an important factor to control the separation efficiency and migration times [27,43]. Initially, a 50 mM concentration of running phosphate buffer was selected; however the internal standard did not separate from pnitrophenol under these conditions.…”
Section: Development Of Ce Methodsmentioning
confidence: 99%
“…Thus, the buffer combination phosphate-HEPES was chosen for the subsequent assay development. The ionic strength of the running buffer is also an important factor to control the separation efficiency and migration times [27,43]. Initially, a 50 mM concentration of running phosphate buffer was selected; however the internal standard did not separate from pnitrophenol under these conditions.…”
Section: Development Of Ce Methodsmentioning
confidence: 99%
“…Genotypic tests were mainly performed through direct sequencing of tk and DNA pol to determine viral susceptibility based on databases of mutations related to ACV resistance. 5,7,8,[12][13][14][15][16] On the other hand, phenotypic evaluations, including plaque reduction assay (PRA), 17 dye uptake assay, and virus yield reduction assay, [18][19][20][21][22] were largely conducted on HSV infections that induced the cytopathic effect. These assays are time consuming, laborious, and hence inconvenient for routine clinical screening.…”
Section: Introductionmentioning
confidence: 99%
“…Our group has long-standing experience in the quantification of nucleotides by CE, and especially in enzyme assays involving the formation or transformation of nucleotides [15][16][17][18][19][20][21][22]. Thus we decided to quantify the nucleotide PAP which is formed from the co-substrate PAPS during the CST reaction.…”
Section: Development and Optimization Of Ce Methods For Monitoring Cstmentioning
confidence: 99%